TipRanks
Allarity Therapeutics, Inc. (ALLR)
NASDAQ:ALLR
US Market
ALLR
Allarity Therapeutics
RESEARCH TOOLSreports
Want to see ALLR full AI Analyst Report?

Allarity Therapeutics (ALLR) Ratios

373 Followers

Allarity Therapeutics Ratios

ALLR's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, ALLR's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Dec 23Mar 23
Liquidity Ratios
Current Ratio
 1.11 2.13 2.06 0.14 0.44
Quick Ratio
 1.11 2.13 2.06 0.14 0.44
Cash Ratio
 0.59 1.74 1.80 0.01 0.18
Solvency Ratio
 -0.43 -1.33 -2.26 -0.81 -1.26
Operating Cash Flow Ratio
 -0.48 -1.76 -1.60 -0.90 -1.50
Short-Term Operating Cash Flow Coverage
 -0.62 -10.59 -12.85 -9.80 -6.36
Net Current Asset Value
$ 3.15M$ 9.50M$ 11.50M$ -12.64M$ -7.69M
Leverage Ratios
Debt-to-Assets Ratio
 0.69 0.08 0.06 0.11 0.26
Debt-to-Equity Ratio
 6.30 0.14 0.11 -0.47 1.98
Debt-to-Capital Ratio
 0.86 0.12 0.10 -0.90 0.66
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.36
Financial Leverage Ratio
 9.08 1.86 1.92 -4.31 7.70
Debt Service Coverage Ratio
 -0.47 -6.97 -11.91 -6.32 -5.50
Interest Coverage Ratio
 -10.15 -68.14 -41.72 -34.40 -154.54
Debt to Market Cap
 1.33 0.09 0.72 <0.01 <0.01
Interest Debt Per Share
 1.47 0.11 1.25 0.54 348.97
Net Debt to EBITDA
 -0.48 1.20 0.75 -0.10 -0.10
Profitability Margins
Gross Profit Margin
107.54%100.00%0.00%0.00%0.00%
EBIT Margin
-3195.07%-3451.87%0.00%0.00%0.00%
EBITDA Margin
-3213.04%-3451.87%0.00%0.00%0.00%
Operating Profit Margin
-3128.99%-3939.06%0.00%0.00%0.00%
Pretax Profit Margin
-3575.07%-3509.69%0.00%0.00%0.00%
Net Profit Margin
-3575.07%-3509.69%0.00%0.00%0.00%
Continuous Operations Profit Margin
-3575.07%-3509.69%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%98.47%100.70%91.35%
EBT Per EBIT
114.26%89.10%91.39%68.99%51.01%
Return on Assets (ROA)
-38.41%-61.51%-108.23%-100.33%-110.41%
Return on Equity (ROE)
-152.77%-114.28%-207.56%432.61%-849.63%
Return on Capital Employed (ROCE)
-305.29%-128.26%-230.64%743.12%-1037.42%
Return on Invested Capital (ROIC)
-41.81%-112.26%-203.82%1704.38%-526.97%
Return on Tangible Assets
-38.41%-61.51%-108.23%-597.74%-321.48%
Earnings Yield
-73.83%-72.32%-1303.87%-1085.07%-573.69%
Efficiency Ratios
Receivables Turnover
 0.26 0.36 0.00 0.00 0.00
Payables Turnover
 >-0.01 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.89 0.97 0.00 0.00 0.00
Asset Turnover
 0.01 0.02 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.07 0.03 0.00 0.00 0.00
Cash Conversion Cycle
 59.13K 1.02K 0.00 0.00 0.00
Days of Sales Outstanding
 1.39K 1.02K 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 -57.74K 0.00 0.00 0.00 0.00
Operating Cycle
 1.39K 1.02K 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.86 -1.03 -10.80 -3.84 -1.48K
Free Cash Flow Per Share
 -0.87 -1.03 -10.98 -3.84 -1.48K
CapEx Per Share
 <0.01 <0.01 0.19 0.00 1.59
Free Cash Flow to Operating Cash Flow
 1.01 1.00 1.02 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -214.22 -1.85K -58.23 0.00 -934.28
Capital Expenditure Coverage Ratio
 -214.22 -1.85K -58.23 0.00 -934.28
Operating Cash Flow Coverage Ratio
 -0.62 -10.59 -12.85 -9.80 -4.50
Operating Cash Flow to Sales Ratio
 -39.74 -46.31 0.00 0.00 0.00
Free Cash Flow Yield
-82.50%-95.48%-938.74%-1162.02%-601.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.35 -1.38 -0.07 -92.16 -174.31
Price-to-Sales (P/S) Ratio
 48.42 48.53 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 4.72 1.58 0.16 -398.69 1.48K
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.21 -1.05 -0.11 -86.06 -166.26
Price-to-Operating Cash Flow Ratio
 -1.22 -1.05 -0.11 -86.06 -166.44
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 0.01 <0.01 0.92 3.69
Price-to-Fair Value
 4.72 1.58 0.16 -398.69 1.48K
Enterprise Value Multiple
 -1.99 -0.20 0.67 -97.31 -161.93
Enterprise Value
 22.01M 2.24M -16.30M 2.23M 4.51M
EV to EBITDA
 -1.99 -0.20 0.67 -0.20 -0.26
EV to Sales
 63.80 7.01 0.00 0.00 0.00
EV to Free Cash Flow
 -1.60 -0.15 0.92 -0.18 -0.27
EV to Operating Cash Flow
 -1.61 -0.15 0.94 -0.18 -0.27
Tangible Book Value Per Share
 0.22 0.68 7.35 -3.81 -675.29
Shareholders’ Equity Per Share
 0.22 0.68 7.35 -0.83 166.64
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.02 >-0.01 0.09
Revenue Per Share
 0.02 0.02 0.00 0.00 0.00
Net Income Per Share
 -0.78 -0.78 -15.26 -3.59 -1.42K
Tax Burden
 1.00 1.00 0.98 1.01 0.91
Interest Burden
 1.12 1.02 1.03 1.04 1.01
Research & Development to Revenue
 16.00 20.63 0.00 0.00 0.00
SG&A to Revenue
 16.29 19.76 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.98 1.51 0.00 0.00 0.00
Income Quality
 1.11 1.32 0.71 1.07 1.05
Currency in USD